Trustees Of Indiana UniversityThe NOD Study is comprised of a baseline visit, follow-up (Year 1 & 2) visits, and an optional patient visit in Year 3. Each visit will include a blood draw and…
$131,887
The Ohio State UniversityThe NOD Study is comprised of a baseline visit, follow-up (Year 1 & 2) visits, and an optional patient visit in Year 3. Each visit will include a blood draw and…
$78,257
Fred Hutchinson Cancer CenterScope of Work for NOD DMCC: „h Manage and distribute protocol modifications to CPDPC, NCORP and KPSC „h Submit protocol modifications to Fred…
$608,985
The Leland Stanford Junior UniversityThe NOD Study is comprised of a baseline visit, follow-up (Year 1 & 2) visits, and an optional patient visit in Year 3. Each visit will include a blood draw and…
Kaiser Foundation HospitalsPancreatic cancer is the third leading cause of cancer death in the United States. A major reason for the lethal nature of this disease is the lack of effective…
$350,000
Kaiser Foundation HospitalsThe NOD Study is comprised of a baseline visit, follow-up (Year 1 & 2) visits, and an optional patient visit in Year 3. Each visit will include a blood draw and…
Cedars-Sinai Medical CenterThe NOD Study is comprised of a baseline visit, follow-up (Year 1 & 2) visits, and an optional patient visit in Year 3. Each visit will include a blood draw and…
$7,247
Adventist Health System / Sunbelt Inc.The NOD study will assemble a cohort of subjects with New-Onset Hyperglycemia and Diabetes (the NOD cohort) in order to estimate the probability of pancreatic…
$3,882
Fred Hutchinson Cancer Center„h Manage and distribute protocol modifications to CPDPC, NCORP and KPSC „h Submit protocol modifications to Fred Hutch IRB „h Coordinate…
$142,570
Spartanburg Regional Health Services District, Inc.The NOD Study is comprised of a baseline visit, follow-up (Year 1 & 2) visits, and an optional patient visit in Year 3. Each visit will include a blood draw and…
$115,712
Adventist Health System / Sunbelt Inc.The NOD study will assemble a cohort of subjects with New-Onset Hyperglycemia and Diabetes (the NOD cohort) in order to estimate the probability of pancreatic…
$256,158
Kaiser Foundation HospitalsPancreatic cancer is the third leading cause of cancer death in the United States. A major reason for the lethal nature of this disease is the lack of effective…
$1,821,673
Henry Ford Health SystemHenry Ford will participate as a subcontractor under MD Anderson for the NIH’s study entitled “A Prospective Study to Establish a New Onset…
Kaiser Foundation HospitalsPayment will be issued on a per visit basis. In order to receive payment, each invoice must include the following: ï‚· PI’s name ï‚· PO number…
$2,097,416
The Leland Stanford Junior UniversityThe NOD Study is comprised of a baseline visit, follow-up (Year 1 & 2) visits, and an optional patient visit in Year 3. Each visit will include a blood draw and…
$68,270
Fred Hutchinson Cancer Research CenterManage and distribute protocol modifications to CPDPC, NCORP and KPSC Submit protocol modifications to Fred Hutch IRB Coordinate regular conference calls,…
$3,478,670
Show all 22
Quick answers
Who received award U01DK108328?
U01DK108328 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 28, 2015.
How much is award U01DK108328 worth?
$44,568,890 has been obligated on U01DK108328: $43,728,197 in federal funding and $840,693 in non-federal funding.
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services